Pulmonx Corporation
LUNG
$1.62
-$0.01-0.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.32% | 1.00% | -5.08% | 5.13% | 5.07% |
| Total Depreciation and Amortization | -34.57% | -25.25% | -34.28% | 2.44% | -9.40% |
| Total Amortization of Deferred Charges | 27.27% | -7.14% | -31.25% | 13,192.31% | -15.38% |
| Total Other Non-Cash Items | -0.47% | -19.72% | -6.90% | -34.65% | -17.14% |
| Change in Net Operating Assets | -115.52% | 255.72% | -3.33% | 286.97% | 180.80% |
| Cash from Operations | -12.70% | 32.27% | -12.10% | 20.35% | 16.04% |
| Capital Expenditure | 78.61% | 89.55% | 33.26% | 44.50% | 15.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.78% | 1,608.20% | 908.07% | 654.91% | 384.58% |
| Cash from Investing | 29.03% | 755.21% | 750.70% | 610.60% | 583.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -4.35% | -- | -4.26% | -- |
| Issuance of Common Stock | -55.34% | 16.67% | -23.15% | 73.44% | -19.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.57% | -204.55% | -23.15% | 264.71% | -19.61% |
| Foreign Exchange rate Adjustments | 398.32% | -1,167.39% | -318.75% | 191.90% | -158.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 818.54% | 113.68% | 127.26% | 166.61% | 97.80% |